BioSpace News Archive

You should always add an executive summary for resumes because they show what you bring to the table. Here’s what you can add to your executive summary.

Pure Sunfarms’ large-scale facility with 16 grow rooms is optimized for year-round production and expected to yield more than 80 harvests annually

Takeda Pharmaceutical’s Entyvio outperformed AbbVie’s Humira in a head-to-head comparison in treating ulcerative colitis during a late-stage study, the company said.

Back by popular demand, AmorChem, the innovative Quebec-based seed venture capital fund, is hosting the 5thedition of its KNOCK OUTTM Event, a challenge where the Contenders, academic researchers selected by AmorChem, duke it out in the ring against a panel of Heavyweight champions in order to qualify for a $500,000 financing from AmorChem.

Persons with Alzheimer’s disease have approximately 30% higher risk of head injuries, and 50% higher risk of traumatic brain injuries than persons without Alzheimer’s disease, a recent study from University of Eastern Finland shows.

AiCuris Anti-infective Cures GmbH is one of three companies nominated for the “Deutscher Innovationspreis 2019” in the category Medium-Sized Enterprises

Auris Medical Holding AG announced the publication of an article that presents and discusses in detail the outcomes from the HEALOS Phase 3 trial with AM-111, Auris Medical’s investigational treatment for acute inner ear hearing loss.

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies using its novel viral vector platform technology, provided an update on its progress and development programs.

Axovant has been busy, releasing interim results from two different clinical trials, one for Tay-Sachs, the other for Parkinson’s disease.

On Friday, March 8, Bristol-Myers Squibb executives met with sell-side analysts to sell its $74 billion Celgene buyout.